Result of General Meeting

Sphere Medical Holding plc

("Sphere Medical" or the "Company")

Result of General Meeting

Sphere Medical Holding plc (AIM: SPHR.L) announces that at the General Meeting held earlier today, all the resolutions proposed were unanimously passed.

The full text of the resolutions can be found in the Notice of the Meeting in the Circular published by the Company on 28 June 2013 and on the Company's website www.spheremedical.com.

Application has been made to AIM, a market of the London Stock Exchange plc, for the admission of 22,403,016 New Ordinary Shares. It is expected that Admission will become effective on 17 July 2013. Following Admission, the Company will have 59,208,660 Ordinary Shares in issue.

Unless otherwise defined, terms in this announcement shall have the same meanings as those defined in the shareholder circular dated 28 June 2013.

For further information, please contact:

About Sphere Medical

Sphere Medical (AIM: SPHR.L), is a medical device company developing a range of innovative monitoring and diagnostic devices designed to significantly improve patient care.

Sphere Medical's Proxima and Cardiopulmonary Bypass devices deliver real time analysis of blood gases, electrolytes, glucose and drug levels with laboratory accuracy, at the patient's bedside. Globally over 240 million blood gas and electrolyte tests are carried out on patients every year in critical care and there is an unmet need for monitoring products that are small, simple to use and cost effective with improved functionality. Sphere Medical's products can be used in a wide range of medical applications enabling faster clinical decision making and consequently improved patient outcomes, whilst also reducing costs for healthcare payers.

Sphere Medical is headquartered in Cambridge, UK and employs around 60 people. The Company has existing commercial partnerships with the leading global medical device companies. For further information, please visit www.spheremedical.com